Suraksha Diagnostic Limited (NSE:SURAKSHA)
India · Delayed Price · Currency is INR 283.80
+7.35 (2.66%)
Feb 19, 2026, 3:29 PM IST
Suraksha Diagnostic Revenue
Suraksha Diagnostic had revenue of 776.87M INR in the quarter ending December 31, 2025, with 29.24% growth. This brings the company's revenue in the last twelve months to 2.94B, up 21.21% year-over-year. In the fiscal year ending March 31, 2025, Suraksha Diagnostic had annual revenue of 2.52B with 15.26% growth.
Revenue (ttm)
2.94B
Revenue Growth
+21.21%
P/S Ratio
4.90
Revenue / Employee
2.26M
Employees
1,300
Market Cap
14.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.52B | 333.84M | 15.26% |
| Mar 31, 2024 | 2.19B | 285.75M | 15.03% |
| Mar 31, 2023 | 1.90B | -330.59M | -14.81% |
| Mar 31, 2022 | 2.23B | 831.87M | 59.42% |
| Mar 31, 2021 | 1.40B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| Indoco Remedies | 17.60B |
| Shalby | 11.19B |
| Windlas Biotech | 8.68B |
| Ind-Swift Laboratories | 5.94B |